UroGen Pharma Ltd. earnings per share and revenue

URGN earnings per share for the last quarter are -0.80 USD whereas the estimation was -0.72 USD which accounts for -11.16% surprise. Company revenue for the same period amounts to 24.57 M USD despite the estimated figure of 25.63 M USD. Estimated earnings per share for the next quarter are -0.80 USD, and revenue is expected to reach 22.69 M USD. Also watch annual changes over time to get a bigger picture of URGN earnings per share and revenue dynamics.